Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
about
The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionVariation in mitochondrial genome primary sequence among whole-genome-sequenced strains of Neurospora crassa.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicityProtein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseaseInvolvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.No evidence of impaired gastric emptying in early Huntington's Disease.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate.Mitochondria, Amyloid β, and Alzheimer's DiseaseProteomic identification of carbonylated proteins in 1,3-dinitrobenzene neurotoxicity.Increased plasma levels of heat shock protein 70 associated with subsequent clinical conversion to mild cognitive impairment in cognitively healthy elderlyThe hypothalamus in Alzheimer's disease: a Golgi and electron microscope study.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.Thidoredxin-2 overexpression fails to rescue chronic high calorie diet induced hippocampal dysfunction.Different Forms of Selenoprotein M Differentially Affect Aβ Aggregation and ROS GenerationOxidative modification of lipoic acid by HNE in Alzheimer disease brain.Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.Basic mechanisms of neurodegeneration: a critical update.Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases.Infectious agents and neurodegeneration.Mitochondrial decay in ageing: 'Qi-invigorating' schisandrin B as a hormetic agent for mitigating age-related diseases.Oxidative stress and β-amyloid protein in Alzheimer's disease.The development of effective biomarkers for Alzheimer's disease: a review.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects.Inverse Association Between Serum Uric Acid Levels and Alzheimer's Disease Risk.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageEnergy metabolism and inflammation in brain aging and Alzheimer's disease.FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells.Clinical aspects of melatonin intervention in Alzheimer's disease progressionNR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats.
P2860
Q26827320-55F70C1A-79B5-4C2C-AB69-A0DB3D988A7DQ26865358-43317F0D-419D-4928-ABEA-224B5F48B5A3Q30423678-C9233E61-31AC-44F2-8380-9F4A5B8B9285Q30446460-21F25C9F-6681-4EED-90D4-E5353E458234Q33784466-A5A4771C-CC52-4E4F-B8DF-1975E1C19EB1Q33857238-1CAAAE7F-591F-45B7-9A44-0B022CB5E145Q33915362-83580CE7-8BF5-49A1-94A6-C89C756E0321Q34087126-E9604930-F891-4B22-9953-C173543B7CA4Q34094516-A8DF4173-6ECC-4A26-B631-71399F49A911Q34193337-915162F9-C335-43EA-A70B-F7AB20C926E8Q34559742-F5123FB2-2927-4F14-98D2-E16E9EB6F808Q34922777-BB44DFF8-61F8-4FCD-8984-CAD07A94D329Q35172263-D80F804A-454D-441C-806E-71E7AB51D6EAQ35175654-56BF98AC-2FDE-47B8-95D6-03246C656446Q35404510-95145C20-493D-403A-B951-FC84CBF1A6E2Q35895780-2D86EDD5-9748-4D65-A551-6591E47AC695Q35908404-B7E67453-B055-4A00-AAE9-C340FC7AFB30Q36026546-A82DD1B6-BF54-49F6-854E-24A2EB340632Q36231595-25EBB264-786D-4C14-99E0-15ECD5090088Q36243522-77563622-0C71-4D6F-B79F-DCEE4760598BQ36395944-7EB90083-6117-4A13-98EB-228293D4404BQ36790354-08F8C234-837B-4978-BB99-451935ECE32FQ37133480-16E31547-530C-4110-B9B2-2368921A596EQ37361122-15049F56-4207-4204-9818-24ED5F8FC1DBQ37384973-8D18394D-D330-4D3E-B5C2-203E56138F9AQ37613081-3EAF2EEC-4579-4317-A48A-8DB63E070232Q37673274-76648AE6-C44D-40C0-B41E-901501AAACE3Q37763932-E2DFEC14-1FE1-46F2-A2D4-8430BAF947DFQ37848266-1F2DE1D8-3E93-4737-B61F-5C45CF1CAC7BQ37927146-D71929D5-FB17-4BAB-9B4E-9EA01C6FDD1EQ37928994-DCE2CCD3-CC88-4C5F-BFA2-F7B6BE36EA7DQ38016800-91EEE20C-4C8C-43FB-B5CA-76CAEA6F510DQ38050263-1ACD04DF-BCE3-40D5-BE40-A1ACC1C02939Q38367422-7F325BB3-7E66-462A-B780-BC52FC61623FQ38530412-DA5285D5-C844-47D6-A317-28330487342DQ38793564-2BA6521C-4861-4C57-AFF3-980F87BB5B9AQ38828060-616246D5-53B3-40B6-8917-3EF0E31E744BQ39090889-6FC515DA-73A7-4160-9449-749C42C55290Q41136734-8ECAB200-3CE0-440D-B430-EC724019E723Q42502548-83AF4022-B02F-4725-B04F-39291C0E4166
P2860
Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@ast
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@en
type
label
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@ast
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@en
prefLabel
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@ast
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@en
P2860
P1476
Oxidatively modified, mitochon ...... and mild cognitive impairment.
@en
P2093
Rukhsana Sultana
P2860
P2888
P304
P356
10.1007/S10863-009-9241-7
P577
2009-10-01T00:00:00Z
P5875
P6179
1012581884